Cargando…
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
The development of monoclonal antibody treatments for successful tumor-targeted therapies took several decades. However, the efficacy of antibody-based therapy is still confined and desperately needs further improvement. Nanobodies are the recombinant variable domains of heavy-chain-only antibodies,...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997558/ https://www.ncbi.nlm.nih.gov/pubmed/33790553 http://dx.doi.org/10.2147/IJN.S297631 |